Caisse de depot et placement du Quebec Buys New Stake in HCA Healthcare, Inc. $HCA

Key Points

• Caisse de dépôt et placement du Québec acquired 66,217 HCA Healthcare shares during the second quarter, valued at approximately $25.8 million. Institutional investors collectively own 62.73% of HCA’s outstanding stock.
• Analysts maintain a broadly positive outlook, with 14 Buy, eight Hold, and one Sell rating. HCA has a “Moderate Buy” consensus rating and an average price target of $462.64.
• HCA exceeded quarterly expectations with $7.59 in earnings per share and $20.23 billion in revenue, up 8.7% year over year. The company also announced a quarterly dividend of $0.78 per share, representing a 0.7% annualized yield.

Caisse de depot et placement du Quebec acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 66,217 shares of the company's stock, valued at approximately $25,817,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. Palisade Asset Management LLC purchased a new stake in HCA Healthcare during the third quarter valued at $26,000. MidFirst Bank bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $28,000. Clearstead Trust LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $29,000. Cedar Mountain Advisors LLC bought a new position in shares of HCA Healthcare during the 1st quarter valued at approximately $33,000. Finally, JPL Wealth Management LLC bought a new position in HCA Healthcare during the third quarter valued at $33,000. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on HCA shares. UBS Group reduced their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Cantor Fitzgerald dropped their price objective on HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating for the company in a report on Tuesday, July 7th. Morgan Stanley lowered their target price on shares of HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating for the company in a research note on Monday, July 27th. Wells Fargo & Company boosted their price objective on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an "equal weight" rating in a research report on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a research note on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $462.64.

HCA Healthcare Stock Down 0.4%

HCA stock opened at $417.57 on Friday. The stock has a market capitalization of $90.40 billion, a PE ratio of 13.98, a price-to-earnings-growth ratio of 1.46 and a beta of 1.10. The firm has a 50 day moving average of $401.08 and a 200 day moving average of $441.46. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company's quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.84 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source